INDI MOLECULAR
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. PCCs were created in collaboration with the California Institute of Technology using “click chemistry,” a synthetic process that allows scientists to permanently join (“click”) together molecular components with remarkable precision and stability. PCCs offer the promise of improved selectivity, super... ior binding affinity, fully synthetic composition and a vastly low molecular weight compared to monoclonal antibodies, the current standard for identifying biomarkers in most diagnostics platforms – and in many therapeutic uses. The company launched as a spinout from its parent company Integrated Diagnostics (Indi) in 2013 with a $1.5 million seed round led by InterWest Partners together with several angel investors.
INDI MOLECULAR
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2013-01-01
Address:
Culver City, California, United States
Country:
United States
Website Url:
http://www.indimolecular.com
Total Employee:
1+
Status:
Active
Contact:
(415) 902-1241
Total Funding:
13.3 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail Facebook Sharer
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Current Advisors List
Board_member
Board_observer
Current Employees Featured
Albert A. Luderer CEO @ Indi Molecular
CEO
2013-09-01
Heather Agnew Director of Research & Development @ Indi Molecular
Director of Research & Development
Albert A. Luderer CEO, Co-Founder & Board Member @ Indi Molecular
CEO, Co-Founder & Board Member
Founder
Investors List
M Ventures
M Ventures investment in Series A - Indi Molecular
SABEY
SABEY investment in Series A - Indi Molecular
Legend Capital
Legend Capital investment in Series A - Indi Molecular
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series A - Indi Molecular
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Seed Round - Indi Molecular
InterWest Partners
InterWest Partners investment in Seed Round - Indi Molecular
Official Site Inspections
http://www.indimolecular.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Indi Molecular"
indimolecular
Indi Molecular® has developed synthetic small molecule targeted oncology therapeutics against overexpressed folate receptors in ovarian cancer and KRAS G12D expressing pancreatic …See details»
Company — indimolecular
About Us. Indi Molecular has developed two oncology therapeutic lead molecules using a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein …See details»
Indi Molecular - Crunchbase Company Profile & Funding
Contact Email info@indimolecular.com Phone Number (415) 902-1241 Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and …See details»
Executives - indimolecular
LOCATION 5877 Obama Blvd, Los Angeles, CA 90016. © Copyright 2024 Indi Molecular, Inc. All Rights Reserved.See details»
Indi Molecular - LinkedIn
Indi Molecular Biotechnology Research Culver City, California 211 followers Indi Molecular is an emerging life sciences company developing synthetic molecules with antibody-like properties.See details»
Indi Molecular, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Indi Molecular, Inc. of Los Angeles, CA. Get the latest business insights from Dun & Bradstreet.See details»
Indi Molecular Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Indi Molecular. Use the PitchBook Platform to explore the full profile.See details»
Indi Molecular, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jul 10, 2023 Explore Indi Molecular, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 2 literature.See details»
Indi Molecular Company Profile | Management and Employees List …
Www.indimolecular.com . Indi Molecular Profile and History. Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents …See details»
Indi Molecular | VentureRadar
Website: http://www.IndiMolecular.com. Develops innovative, small synthetic molecules as an alternative to traditional antibody-based therapeutics, enhancing ...See details»
Board - indimolecular
LOCATION 5877 Obama Blvd, Los Angeles, CA 90016. © Copyright 2024 Indi Molecular, Inc. All Rights Reserved.See details»
Indi Molecular - VentureRadar
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like... ... Find out more ...See details»
Indi Molecular - Craft
Indi Molecular has 5 employees at their 1 location and $11.5 m in total funding,. See insights on Indi Molecular including office locations, competitors, revenue, financials, executives, …See details»
Indi Molecular - Biotech Careers
Indi Molecular is developing protein catalyzed capture (PCC) agents as a small synthetic molecule replacements for antibody-based therapeutics. PCCs are poised to play a central role in …See details»
Contact — indimolecular
LOCATION 5877 Obama Blvd, Los Angeles, CA 90016. © Copyright 2024 Indi Molecular, Inc. All Rights Reserved.See details»
Indi Molecular Appoints Stephen Worsley Senior VP Business
Dec 20, 2017 The company launched as a spinout from its parent company Integrated Diagnostics (Indi) in 2013 with a $1.8 million seed round, followed by an $11.5 million Series A …See details»
Indi Molecular - VentureRadar
Similar Companies: SynAffix Netherlands Privately Held Formed in 2010, Synaffix BV is a Netherlands-based biotechnology company exclusively focused on continued advancement of …See details»
Indi Molecular, Inc. (Indi Molecular, Inc.) - 药物管线_专利_临床试 …
了解Indi Molecular, Inc. (Indi Molecular, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1篇新闻和2篇文献，疾病领域:肿瘤，内分泌与代谢疾病，技术平台:合成多肽，诊断用放射药物， …See details»
Advisors - indimolecular
LOCATION 5877 Obama Blvd, Los Angeles, CA 90016. © Copyright 2024 Indi Molecular, Inc. All Rights Reserved.See details»
News — indimolecular
Mar 29, 2022 News Indi Molecular Closes Sale of PCC Technology Platform. March 29, 2022 – Today Indi Molecular announced the successful close of the sale of its PCC technology platform.See details»